CD8A and myeloid sarcoma: The fact that CD8+ T cells outnumber CD4+ T cells in MS lesions was first observed in the 80s, in particular in the parenchyma, and was regardless of differing clinical parameters, such as disease duration, disease evolution, and therapy (19).